UNIVERSAL HEALTH SERVICES-B (UHS) Fundamental Analysis & Valuation

NYSE:UHS • US9139031002

Current stock price

167 USD
-1.27 (-0.75%)
At close:
167 USD
0 (0%)
After Hours:

This UHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UHS Profitability Analysis

1.1 Basic Checks

  • UHS had positive earnings in the past year.
  • In the past year UHS had a positive cash flow from operations.
  • In the past 5 years UHS has always been profitable.
  • UHS had a positive operating cash flow in each of the past 5 years.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • UHS has a Return On Assets of 9.59%. This is amongst the best in the industry. UHS outperforms 94.00% of its industry peers.
  • UHS has a Return On Equity of 20.46%. This is amongst the best in the industry. UHS outperforms 89.00% of its industry peers.
  • UHS's Return On Invested Capital of 12.52% is amongst the best of the industry. UHS outperforms 88.00% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for UHS is in line with the industry average of 8.40%.
  • The 3 year average ROIC (10.23%) for UHS is below the current ROIC(12.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROIC 12.52%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • UHS has a Profit Margin of 8.57%. This is amongst the best in the industry. UHS outperforms 91.00% of its industry peers.
  • UHS's Profit Margin has been stable in the last couple of years.
  • With an excellent Operating Margin value of 11.48%, UHS belongs to the best of the industry, outperforming 83.00% of the companies in the same industry.
  • UHS's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.48%
PM (TTM) 8.57%
GM N/A
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

4

2. UHS Health Analysis

2.1 Basic Checks

  • UHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • UHS has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for UHS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, UHS has an improved debt to assets ratio.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • UHS has an Altman-Z score of 2.95. This is not the best score and indicates that UHS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • UHS has a Altman-Z score of 2.95. This is in the better half of the industry: UHS outperforms 66.00% of its industry peers.
  • UHS has a debt to FCF ratio of 5.60. This is a neutral value as UHS would need 5.60 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 5.60, UHS perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
  • UHS has a Debt/Equity ratio of 0.55. This is a neutral value indicating UHS is somewhat dependend on debt financing.
  • UHS's Debt to Equity ratio of 0.55 is in line compared to the rest of the industry. UHS outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Altman-Z 2.95
ROIC/WACC1.55
WACC8.05%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • UHS has a Current Ratio of 1.05. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
  • UHS has a worse Current ratio (1.05) than 67.00% of its industry peers.
  • A Quick Ratio of 0.98 indicates that UHS may have some problems paying its short term obligations.
  • UHS's Quick ratio of 0.98 is on the low side compared to the rest of the industry. UHS is outperformed by 68.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.98
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

5

3. UHS Growth Analysis

3.1 Past

  • UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.77%, which is quite impressive.
  • The Earnings Per Share has been growing by 14.35% on average over the past years. This is quite good.
  • UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.71%.
  • The Revenue has been growing by 8.48% on average over the past years. This is quite good.
EPS 1Y (TTM)26.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%16.12%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.65%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.62% on average over the next years.
  • The Revenue is expected to grow by 6.10% on average over the next years.
EPS Next Y8.94%
EPS Next 2Y8.95%
EPS Next 3Y9.21%
EPS Next 5Y7.62%
Revenue Next Year6.49%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y6.1%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10 20 30 40

8

4. UHS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.41, the valuation of UHS can be described as very cheap.
  • 96.00% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 26.64. UHS is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 6.47 indicates a rather cheap valuation of UHS.
  • Based on the Price/Forward Earnings ratio, UHS is valued cheaply inside the industry as 97.00% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.36, UHS is valued rather cheaply.
Industry RankSector Rank
PE 7.41
Fwd PE 6.47
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaper than 93.00% of the companies in the same industry.
  • UHS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UHS is cheaper than 79.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 12
EV/EBITDA 5.7
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of UHS may justify a higher PE ratio.
PEG (NY)0.83
PEG (5Y)0.52
EPS Next 2Y8.95%
EPS Next 3Y9.21%

5

5. UHS Dividend Analysis

5.1 Amount

  • UHS has a yearly dividend return of 0.48%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.46, UHS pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.48, UHS pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.48%

5.2 History

  • On average, the dividend of UHS grows each year by 32.23%, which is quite nice.
  • UHS has paid a dividend for at least 10 years, which is a reliable track record.
  • UHS has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)32.23%
Div Incr Years0
Div Non Decr Years5
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • 3.44% of the earnings are spent on dividend by UHS. This is a low number and sustainable payout ratio.
  • UHS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP3.44%
EPS Next 2Y8.95%
EPS Next 3Y9.21%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UHS Fundamentals: All Metrics, Ratios and Statistics

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (5/1/2026, 8:04:00 PM)

After market: 167 0 (0%)

167

-1.27 (-0.75%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength60.87
Industry Growth63.98
Earnings (Last)04-27
Earnings (Next)07-27
Inst Owners97.39%
Inst Owner Change-0.26%
Ins Owners6.17%
Ins Owner Change9.29%
Market Cap10.19B
Revenue(TTM)17.36B
Net Income(TTM)1.49B
Analysts70.77
Price Target252.4 (51.14%)
Short Float %4.11%
Short Ratio2.8
Dividend
Industry RankSector Rank
Dividend Yield 0.48%
Yearly Dividend0.81
Dividend Growth(5Y)32.23%
DP3.44%
Div Incr Years0
Div Non Decr Years5
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-1.33%
Max EPS beat(2)16.52%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-1.33%
Max EPS beat(4)16.52%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)11
Avg EPS beat(12)9.91%
EPS beat(16)13
Avg EPS beat(16)6.42%
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)2.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)8
Avg Revenue beat(12)0.15%
Revenue beat(16)12
Avg Revenue beat(16)0.29%
PT rev (1m)0.46%
PT rev (3m)-0.5%
EPS NQ rev (1m)0.55%
EPS NQ rev (3m)2.21%
EPS NY rev (1m)-0.63%
EPS NY rev (3m)-0.47%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)1.33%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.45%
Valuation
Industry RankSector Rank
PE 7.41
Fwd PE 6.47
P/S 0.59
P/FCF 12
P/OCF 5.47
P/B 1.4
P/tB 3.1
EV/EBITDA 5.7
EPS(TTM)22.54
EY13.5%
EPS(NY)25.83
Fwd EY15.47%
FCF(TTM)13.92
FCFY8.33%
OCF(TTM)30.55
OCFY18.29%
SpS284.53
BVpS119.22
TBVpS53.84
PEG (NY)0.83
PEG (5Y)0.52
Graham Number245.888 (47.24%)
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROCE 16.23%
ROIC 12.52%
ROICexc 12.66%
ROICexgc 18.85%
OM 11.48%
PM (TTM) 8.57%
GM N/A
FCFM 4.89%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
ROICexc(3y)10.34%
ROICexc(5y)9.46%
ROICexgc(3y)15.38%
ROICexgc(5y)14.27%
ROCE(3y)13.26%
ROCE(5y)12.14%
ROICexgc growth 3Y22.6%
ROICexgc growth 5Y1.17%
ROICexc growth 3Y23.35%
ROICexc growth 5Y3.38%
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Debt/EBITDA 1.53
Cap/Depr 164.07%
Cap/Sales 5.85%
Interest Coverage 12.78
Cash Conversion 71.36%
Profit Quality 57.04%
Current Ratio 1.05
Quick Ratio 0.98
Altman-Z 2.95
F-Score8
WACC8.05%
ROIC/WACC1.55
Cap/Depr(3y)152.09%
Cap/Depr(5y)148.58%
Cap/Sales(3y)5.67%
Cap/Sales(5y)5.85%
Profit Quality(3y)76.18%
Profit Quality(5y)54.04%
High Growth Momentum
Growth
EPS 1Y (TTM)26.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%16.12%
EPS Next Y8.94%
EPS Next 2Y8.95%
EPS Next 3Y9.21%
EPS Next 5Y7.62%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.65%
Revenue Next Year6.49%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y6.1%
EBIT growth 1Y18.56%
EBIT growth 3Y25.72%
EBIT growth 5Y7.99%
EBIT Next Year33.33%
EBIT Next 3Y12.69%
EBIT Next 5Y9.47%
FCF growth 1Y-24.4%
FCF growth 3Y47.99%
FCF growth 5Y-12.18%
OCF growth 1Y-9.81%
OCF growth 3Y23.24%
OCF growth 5Y-4.61%

UNIVERSAL HEALTH SERVICES-B / UHS Fundamental Analysis FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


How profitable is UNIVERSAL HEALTH SERVICES-B (UHS) stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for UHS stock?

The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 7.41 and the Price/Book (PB) ratio is 1.4.


How financially healthy is UNIVERSAL HEALTH SERVICES-B?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 4 / 10.